You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 8, August 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Neuromuscular diseases
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phenotypic Study in 40 Patients With Dysferlin Gene Mutations

High Frequency of Atypical Phenotypes

Karine Nguyen, MD; Guillaume Bassez, MD; Martin Krahn, MD; Rafaelle Bernard, MD; Pascal Laforêt, MD; Véronique Labelle, BSc; Jon Andoni Urtizberea, MD; Dominique Figarella-Branger, MD, PhD; Norma Romero, MD; Shahram Attarian, MD; France Leturcq, PhD; Jean Pouget, MD; Nicolas Lévy, MD, PhD; Bruno Eymard, MD, PhD

Arch Neurol. 2007;64(8):1176-1182.

Objective  To describe the phenotypic spectrum of dysferlin (DYSF) gene mutations (which cause dysferlinopathies, autosomal recessive muscular dystrophies) in patients with a dysferlin protein deficiency.

Design  Clinical, biological, and pathological data from 40 patients were reviewed. The diagnosis of dysferlinopathy was based on the absence or strong reduction of dysferlin in muscle, and confirmed by mutational screening of the DYSF gene.

Setting  Two French neuromuscular diseases centers (in Paris and Marseilles).

Results  Two main dysferlinopathy phenotypes are well recognized: Miyoshi myopathy and limb-girdle muscular dystrophy type 2B. Typical Miyoshi myopathy and limb-girdle muscular dystrophy type 2B were found in 20 (50%) patients only. Unusual phenotypes included a mixed phenotype, referred to as "proximodistal," combining distal and proximal onset in 14 (35%) patients, pseudometabolic myopathy in 4 (10%), and asymptomatic hyperCKemia (an increased serum creatine kinase level) in 2 (5%). The disease may worsen rapidly, and 10 (25%) patients were initially misdiagnosed as having polymyositis. We suggest a relationship between proximodistal phenotype, inflammation, and severity.

Conclusion  In addition to typical Miyoshi myopathy and limb-girdle muscular dystrophy type 2B, dysferlinopathies are a clinically heterogeneous group of disorders ranging from asymptomatism to severe functional disability.


Author Affiliations: Département de Génétique Médicale (Drs Nguyen, Krahn, Bernard, and Lévy and Ms Labelle), Laboratoire d’Anatomopathologie (Dr Figarella-Branger), and Service de Neurologie et Maladies Neuromusculaires (Drs Attarian and Pouget), Assistance Publique–Hôpitaux de Marseille, Hôpital Timone, Marseille; Institut de Myologie, Assistance Publique–Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris (Drs Bassez, Laforêt, Romero, and Eymard); Consultation Neuromusculaire, Assistance Publique–Hôpitaux de Paris, Hôpital Henri Mondor, Créteil (Dr Bassez); Consultation Neuromusculaire, Assistance Publique– Hôpitaux de Paris, Hôpital Marin, Hendaye (Dr Urtizberea); Laboratoire de Biochimie et Génétique, Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Paris (Dr Leturcq); and INSERM U491: "Génétique Médicale et Développement," Faculté de Médecine Timone, Marseille (Dr Lévy), France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis and management of the limb girdle muscular dystrophies
Bushby
PN 2009;9:314-323.
ABSTRACT | FULL TEXT  

Diagnosis and new treatments in muscular dystrophies
Manzur and Muntoni
Postgrad. Med. J. 2009;85:622-630.
ABSTRACT | FULL TEXT  

Diagnosis and new treatments in muscular dystrophies
Manzur and Muntoni
J. Neurol. Neurosurg. Psychiatry 2009;80:706-714.
ABSTRACT | FULL TEXT  

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
Chiu et al.
Hum Mol Genet 2009;18:1976-1989.
ABSTRACT | FULL TEXT  

Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies
Liewluck
Rheumatology (Oxford) 2009;48:90-90.
FULL TEXT  

Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies: reply
Suzuki et al.
Rheumatology (Oxford) 2009;48:90-91.
FULL TEXT  

Dysferlin Deficiency Shows Compensatory Induction of Rab27A/Slp2a That May Contribute to Inflammatory Onset
Kesari et al.
Am. J. Pathol. 2008;173:1476-1487.
ABSTRACT | FULL TEXT  

Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B
Nagaraju et al.
Am. J. Pathol. 2008;172:774-785.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.